Curis Lifesciences Limited IPO
BBSMENSEListed
Listed at
146.1
+14.14%
Curis Lifesciences Limited IPO is a SME book building IPO. Issue size is 27.52 Cr. Price band is ₹120 to ₹128 per share. Minimum investment is ₹2.56 L. Lot size is 1000 shares. Open from 7 Nov 2025 to 11 Nov 2025. Allotment on 12 Nov 2025. Listing on 14 Nov 2025 at NSE. Managed by Finaax Capital Advisors Private Limited Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.
Curis Lifesciences Limited IPO overview
Curis Lifesciences Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Price band
₹120 to ₹128
Lot size
1000 shares / lot
Min investment
₹2,56,000
Issue open – close
7 Nov 2025 → 11 Nov 2025
Curis Lifesciences Limited IPO important dates
Issue Opens
7 Nov 2025
Issue Closes
11 Nov 2025
Allotment
12 Nov 2025
Listing
14 Nov 2025
Curis Lifesciences Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,56,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,84,000 |
| S-HNI (UPI) | 3 | 3,000 | ₹3,84,000 |
| S-HNI (Max) | 7 | 7,000 | ₹8,96,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,24,000 |
Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.
Quick Profit Calculator for Curis Lifesciences Limited IPO
Pre-filled: Issue Price = ₹128, Lot Size = 1,000 shares, Listing Price = ₹146.1
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,56,000 | ₹146 | +₹36,200 |
| S-HNI (Min) | 3 | ₹3,84,000 | ₹146 | +₹54,300 |
| S-HNI (UPI) | 3 | ₹3,84,000 | ₹146 | +₹54,300 |
| S-HNI (Max) | 7 | ₹8,96,000 | ₹146 | +₹1,26,700 |
| B-HNI (Min) | 8 | ₹10,24,000 | ₹146 | +₹1,44,800 |
Profit based on the official listing price for each investor category.
About Curis Lifesciences Limited IPO
From the company / RHP narrative.
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.
The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing.
The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Products:
General pharmaceutical tablets and capsules
Oral liquids
External preparations
Sterile ophthalmic ointments
The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy.
As of July 31, 2025, the company has 95 permanent employees.
Competitive Strengths:
Experienced Promoters and Management Team
Wide range of Products
Strategic Location of Manufacturing Facility
Scalable Business Model
Quality assurance
Curis Lifesciences Limited IPO Issue Objective
How the issuer plans to use IPO proceeds.
Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities
Capital Expenditure towards Construction of a Storage Facility
Pre-payment/Repayment of outstanding Secured Loans
Product Registrations in other countries
Funding our Working Capital Requirements
General Corporate Purposes
Curis Lifesciences Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.
What is Curis Lifesciences Limited IPO?
Curis Lifesciences Limited IPO is a public issue where the company offers its shares to investors through the stock exchange, allowing retail, HNI, and institutional participation.
What is the IPO price band of Curis Lifesciences Limited IPO?
The IPO price band of Curis Lifesciences Limited IPO is ₹₹120 to ₹128 per share, as mentioned in the issue details.
What is the minimum investment required for Curis Lifesciences Limited IPO?
The minimum investment in Curis Lifesciences Limited IPO is ₹2,56,000, based on the applicable lot size for retail investors.
What is the lot size of Curis Lifesciences Limited IPO?
The lot size of Curis Lifesciences Limited IPO is 1000 shares per lot, and applications must be made in multiples of this lot size.
What are the opening and closing dates of Curis Lifesciences Limited IPO?
Curis Lifesciences Limited IPO opens on 7 Nov 2025 and closes on 11 Nov 2025, as per the announced schedule.
What is Curis Lifesciences Limited IPO subscription status?
Curis Lifesciences Limited IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.
What is Curis Lifesciences Limited IPO GMP today?
Curis Lifesciences Limited IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.
Is Curis Lifesciences Limited IPO GMP positive or negative?
Curis Lifesciences Limited IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.
What does Curis Lifesciences Limited IPO GMP indicate for listing?
A positive Curis Lifesciences Limited IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.
When is Curis Lifesciences Limited IPO listing date?
The expected listing date of Curis Lifesciences Limited IPO is 14 Nov 2025, subject to completion of the allotment process.
Where can I check Curis Lifesciences Limited IPO allotment status?
Curis Lifesciences Limited IPO allotment status can be checked online once the allotment process is completed using application or PAN details.
Can Curis Lifesciences Limited IPO subscription and GMP change before listing?
Yes, Curis Lifesciences Limited IPO subscription figures and GMP may change during the issue period and before listing based on market activity.
Curis Lifesciences Limited IPO Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Loading ratings…